The Drug Reps hated when I quoted a negative review from Medical Letter....it kept me safe and my patients safe.  Less

The Medical Letter provides a thorough yet concise review of medical treatments, their costs, benefits, comparators, and value. It's unbiased and an excellent source of affordable CME and credits toward Maintenance of Certification. I have no reservations recommending it to Internists.  Less

Please be aware that we all rely on The Medical Letter, and have for years for the basic, non-commercial, honest, non-profit information we require to treat our patients effectively and reliably. It's The Medical Letter's old style honesty we fully appreciate! Thanks and accept my support.  Less

It's been 40 years and honestly I couldn't have done it without you. Honesty is a hard quality to come by these days. God bless!!  Less

Even in retirement I value your information above others. You have been with me since my first years in pharmacy.  Less

Have had subscription since 1st year medical school in 1971... one of the very best medical publications, second to none. No other publication keeps one current on medications and also very important there evidence based and also effective off label use.

I try to 'force' it on all the medical students I teach as unfortunately their learning is now focused on programmed offerings and not the medical journals or Medical Letter and researching clinical problems in PubMed. I find this really limits their scope of knowledge in Medicine, programmed learning materials are limited, not really current and often biased. Of course they have now based examinations for advancement entirely on these and are big revenue generators so are hard to thwart. The Medical Letter needs to become forceful and push to be part of all medical student/resident education programs, the medical students I teach (in 3rd-4th years) have never heard of it.

Keep up your good standards--succinct, pertinent, topical and cost of drug revelations.

Your publication should be made mandatory for all medical students and beyond for life.  Less

I wrote a similar note to the Medical Letter about a year ago, but am compelled to send another. I have subscribed to the Medical Letter since the early 1970's, either personal subscription or as director of two statewide drug information centers. Your publication has continued to provide unbiased, clinically relevant information on drugs and therapeutics not available from any source I'm aware of. You are such a welcome, refreshing, and needed source in the continual face of biased approaches of pharmaceutical companies only for financial gain, without any real concern for care of individual patients. YOU have genuine concern for patient care.

So just want to say congratulations again to your great publication. Please keep the unbiased slant strong. It remains sorely needed.  Less

This newsletter was recommended by my Adv. Pharmacology professor eight years ago, so I subscribed to it. I have not regretted this decision one bit and I continue to look forward to the monthly updates in all categories of medications and other medical topics. I wouldn't change a thing.  Less

I especially appreciate the review articles about important classes of drugs, the listing of prices because it is so hard to get elsewhere and varies with insurance, and of course the opportunity to earn CMEs. Thank you all for doing a solid job.  Less

In my view the ML is a treasure. For a relatively small cost, we have access to unbiased reviews of new drugs, as well as reviews of drug classes.. This subscription is a no brainer.   Less

I wish to commend the author(s) of Issue No. 1518. It is an excellent example of what I find most helpful: It is beautifully organized for a nephrologist like me. It gives a very useful summary of the approach to drug therapy of COPD. Instead of emphasizing details about each drug, it provides an overview of how drugs are employed in therapy. It made sense for me in an area with which I am not very familiar. Overall I was left with an approach to therapy of the patient. Congratulations!  Less

I rely on Medical Letter to keep me educated outside my subspecialty of reproductive endocrinology. The unbiased information is excellent.  Less

I started subscribing around 1984, after your product was recommended by a professor at my medical school (McGill University, in Montreal, Canada). And I have been very satisfied ever since. Firstly, I have confidence in your recommendations. Secondly, I like that you mention specifically which medications are approved (or not) in Canada. I usually save every Medical Letter anyway, because many medications first approved in the US do eventually come to Canada.  Less

In 1977, Dr. Montague Lane, Professor of Oncology at Baylor College of Medicine, told his students, ''If you only read one journal after graduating, make it the Medical Letter.'' I haven't forgotten his words, and have subscribed ever since.  Less

I read my first issue as a sophomore medical student in the spring of 1968, on the recommendation from my pharmacology professor, and I have never stopped.

Thank you for your continued dedication to excellence and for helping the thousands of clinicians bridge the enormous gap between what pharmaceutical companies and drug representatives tell us and what the best of science has to offer.

I am proud to have been one of your most avid fans.  Less

As director of two large drug information centers over the years, I have relied on The Medical Letter continuously for unbiased information which simply can't be found in any other single source. I have been a subscriber of The Medical Letter since the early 1970's and have taught pharmacy and medical students the value of your publication.

You have done a remarkable job in presenting drug and therapeutic information to health professionals, cutting through the biased data provided by the drug companies, which has now extended to TV commercials. My quest over the years has been to provide unbiased information to physicians and other health professionals based on critical evaluation of clinical studies and other medical literature, much in the form of your publication. This has included comparative efficacy and safety of pharmacologic agents in specific disease states. None of this information is available through drug manufacturers. All we see is manufacturer Package Inserts and Product Information, carefully worded so as not to show any disadvantage of their product and to cover the legal side. This is a disservice to health care.

Drug information systems, including those I have developed, are available as an alternative to manufacturer data for clinicians. Many have had the original intent of providing critically evaluated information with high clinical relevance, but have succumbed to the business world, where monetary concerns prevail and there is no real understanding of the need for such information and/or fear of drug-company repercussions. Manufacturer product information often supersedes information that is really needed for the practitioner. For example, it is rare to see a dose of a drug that differs from the Package Insert, despite clear evidence of a better dose from a well-designed clinical trial.

Clinical recommendations based on critically evaluated data is essential to improve patient care. But efforts to do this other than The Medical Letter are still struggling. So I applaud your accomplishments over the years. There at least remains one place where health professionals can obtain quality, evaluated, and unbiased data. Please keep up the great work and don't hold back on your critical evaluations. Keep telling it like it should be told.  Less

Thank you for the best medical reference I read! Straightforward, unbiased, clinically useful, always up to date--I've subscribed since medical school. Content quality is consistently high, and you're a terrific way for a specialist to keep up on general internal medical issues and medications.  Less

I have subscribed to THE Medical Letter since the late 1960's or early 70's. I can't remember which. I have been retired from the active practice of Medicine for nearly 16 years but have continued to read and study TML and Treatment Guidelines during this time and I feel as tho I'm up to date on all of the new medicines and treatments that are available now.  Less

Authoritative, evidence-based, and up-to-date information.  Less

Great for knowledge and cme  Less

The best unbiased source of information about drugs on the market.  Less

Timely topics. Concise information  Less

Provides concise reviews of new products and puts them in perspective with existing therapy.  Less

Non-biased, practical concise advice. I especially like Treatment Guidelines for an excellent summary of rx for the most common illnesses.  Less

The Medical Letter provides objective information based on available studies. It points out what data is NOT known. It includes cost information. One can find a summary of information about a medication in one place, and know that the information is as factual as possible.  Less

The references, selection of subjects, presentations, and topical nature of each letter is outstanding and easily applied to clinical practice as well as concurrent chart reviews and financial planning . Cannot be without this important source of information.  Less

I have been a subscriber to The Medical Letter for over 20 yrs. As a small town rural physician, The Medical Letter is usually my first exposure to new therapeutics. It is easy to read in one sitting and the format makes it easy to glean the useful info at a glance. I also participate in the CME program which gives me extra incentive and over half the needed points for one year for Family Medicine  Less

Used it for 22 years for pharmacolgy update and CME. Evidence based, clearly written, non-biased, common sense approach with focus on effciacy and safety and cost effectivelness. My favorite!  Less

I have been a subscriber for over 35 years. Your best source for unbiased,critical information on new drugs, current use, etc.!  Less

I'm now retired. The Medical Letter has long been a credible and professionally valuable source of updated clinical information and source of CME for me.  Less

I have subscribed to the medical letter for over 30 years, since residency it is an unbiased nice review of drugs i dont always trust the drug reps i go read the medical letter before using new drugs  Less

I like the critical-to-the-point-of-skeptical tone of the reviews.  Less

It provides concise, unbiased, authoritative, well referenced, clinically pertinent information.  Less

Objective, thoughtful analysis that you can hang your hat on.  Less

Excellent presentation drug information with recommendations. Excellent CE program helps focus & reinforce important information. Have been a subscriber of both for > 15 yrs & essential to my practice as NP & role as nursing educator in college of nursing.  Less

I'm a hyper-critical SOB. Your unapologetic adherence to clinically & statistically significant data appeal to me. I don't need ads - I get those from the drug reps.  Less

True information about pharmaceuticals Priceless  Less

A succinct summary about medications and treatments that is usually relevant to my practice.  Less

Unbiased, honest up to date information  Less

Concise. scientifically stringent. up to date. analytic evaluations in relationship to real clincial practice. most importantly-- free from Big Pharma influence.  Less

Simple, unbiased reviews and reports that keep those of us not in primary care abreast of the bewildering array of drugs our patients are taking.  Less

Have depended on The Medical Letter for unbiased evaluation of medications and devices for 25 years. Well worth it.  Less

The Medical Letter is a great resource for getting current information on new drugs and to learn about possible problems with drugs on the market. I love that it is very short and concise.  Less

Keeps me current on new meds and treatment guidelines in a very efficient and non-biased fashion. Expeditious CME  Less

unbiased opinions; short; clear; valuable details on things like pricing and if a medication's extra cost is really worth it  Less

no way I could read all those journals trying to keep up with newer medications. very useful  Less

I've read The Medical Letter religiously for years. It offers concise, up-to-date info on drugs, totally free of commercial bias. The cost and efficacy of new drugs is compared with older ones. The compendium articles (statins, antihypertensives, etc etc) are extremely valuable. I give residents a copy of the analgesics guide every year.  Less

it is important for physicians to get NON pharmacy company information, non industry sponsored, about new drugs and comparison with existing treatments helps decide whether to even bother with me-too meds. best source i know for the new -ab drugs: immunosuppresives and drugs tailored for certain diseases. no hype. comparing cost and efficacy across treatments valuable. no ads or bias. not to mention CME! who could ask for anything more.  Less

I find the information very helpful and pleasantly unbiased. I wouldn't miss an issue.  Less

Excellent review of what we should already know (with updates) and excellent coverage of adverse (side) effects with mention of comparative cost on new drugs. (Long time subscriber!) Thanx much for your consistency. R.E. Myer  Less

The Medical Letter provides me with up to date information on drugs and their use. It is quite useful in my practice of pharmacy.  Less

Helps me evaluate whether I will use new medications or not  Less

It helps me keep up with new medicines and those I use every day.  Less

Keeps me up to date, with info coming in small doses  Less

Like the impartial evaluation of new meds with pros and cons.  Less

Low cost and easy to access CME. Up to date unbiased information.  Less

I love the unbiased skeptical review of new medications.  Less

The Medical Letter reviews are unbiased. The guidance for treatment and understanding the conditions being addressed are always clear, concise, well-documented.  Less

Keeps me abreast of new drugs that show up on the med list . Also a small window of insight to what is happening in cardiology ID rheum etc.  Less

Unbiased, concise, evidence based information. Great format, easy to use/quote and share.  Less

I enjoy the objective and honest information. Other journals often have articles which are just advertising.  Less

Up to date and precise pharmacological information.  Less

The Medical Letter gives me information I can trust to be as free of industry bias as possible. The CME program is also excellent, I have used it for years.  Less

With the medical letter information, I have more confidence to discuss medications with patients and to provide my patients up-to-date mediation information.  Less

I feel confident that reading the Medical Letter, every issue, keeps me up to date on pharmaceutical issues.  Less

I love the medical letter. There is no better way to keep up with new pharmaceuticals in an unbiased way! Very succinct format and CME's you can use across all specialties  Less

Honest, unbiased and free of financial influence.  Less

It is one of few sources of non commercially biased pharmaceutical information. Please don't stop what you do! Thank you.  Less

Excellent concise reviews. Appreciate the work you do.  Less

Up to date analysis of new (and older) drugs -- independent  Less

I have subscribed to The Medical Letter for many years. The sheer number of new medications that are developed is mind boggling to me: The Medical Letter introduces me to many of them. I REALLY value the science-based, unbiased reports on medications/vaccines/etc that the Medical Letter gives. I also like getting 26 hours of CME/year by taking the Comprehensive Exams twice a year.  Less

I have been subscribing since 1988. I appreciate how every two weeks I am succinctly kept up to date on the latest treatments or disease management options. I also get CME for it. It is the one source I compulsively read and have done so for almost 30 years.  Less

I just want to say how much I appreciate your consistently well-written reviews not only of medications but of the entire process of medication development, approval, marketing, etc. Your reflections on the industry are a welcome antidote to advertising hype. It is also helpful that you take into account end-cost to consumer; an issue of increasing concern to all my patients with high deductibles and high co-pays.  Less

Medical Letter & the former Treatment Guidelines have been valuable reference resources...giving concise & pertinent info for our practices. I have continually recommended these references to friends & colleagues over the years. Truly OUTSTANDING !!!  Less

With the pharmaceutical industry making each new drug sound like a miracle, it is reassuring to know that there is a source of unbiased information about new and old drugs. There is just enough information about the mechanisms of action of new drugs and sometimes a nice review of the same for older drugs.I am usually not overwhelmed with too much information and tables are generally easy to read. Lastly, I am challenged to pass the little quiz at the end, and it's a great way to get CME.  Less

TML provides me regularly with updated, clearly written and unbiased evaluations of newly-appearing drugs, medications and emerging therapies. Much of this information is immediately applicable to my everyday practice and enables me provide the most up-to-date therapies in the clinical setting.  Less

Solid and scientific presentation of key information on new therapeutic management and introduction of newly released medications. I find the Medical Letter to provide the most helpful clinical information and its approach provides a hard headed and critical advice and communicates the proprer amount of skepticism before clinicians rush to use new and less tested products.  Less

I value ML because of its scrupulous honesty, clarity and completeness of information that is completely untainted by the tentacles of Big Pharma and their advertising and funding policies. I especially like your notations and emphasis that most often, the drug information presented seldom compares the new agent with other drugs in the same pharmacologic category, but only with placebos. In addition to ML, I greatly appreciate Dr A's blog, where he gets to voice personal feelings.  Less